The Cigna Group (NYSE:CI) Shares Bought by Davidson Investment Advisors

Davidson Investment Advisors raised its holdings in The Cigna Group (NYSE:CI) by 1.0% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 53,846 shares of the health services provider’s stock after acquiring an additional 559 shares during the quarter. Davidson Investment Advisors’ holdings in The Cigna Group were worth $14,869,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Collier Financial acquired a new position in shares of The Cigna Group during the 4th quarter worth $32,000. ORG Wealth Partners LLC acquired a new position in shares of The Cigna Group during the 4th quarter worth $34,000. Prospera Private Wealth LLC acquired a new position in shares of The Cigna Group during the 3rd quarter worth $37,000. Compagnie Lombard Odier SCmA acquired a new position in shares of The Cigna Group during the 4th quarter worth $37,000. Finally, Harbor Capital Advisors Inc. acquired a new position in shares of The Cigna Group during the 3rd quarter worth $45,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on the company. Raymond James reaffirmed a “strong-buy” rating and set a $360.00 price target (down previously from $415.00) on shares of The Cigna Group in a research note on Friday, January 31st. Truist Financial dropped their price objective on The Cigna Group from $390.00 to $375.00 and set a “buy” rating for the company in a research report on Tuesday, February 4th. Oppenheimer dropped their price objective on The Cigna Group from $400.00 to $375.00 and set an “outperform” rating for the company in a research report on Friday, January 31st. Barclays lowered their price target on The Cigna Group from $420.00 to $339.00 and set an “overweight” rating for the company in a report on Friday, January 31st. Finally, Sanford C. Bernstein cut The Cigna Group from an “outperform” rating to a “market perform” rating and set a $323.00 price target for the company. in a report on Thursday, February 6th. Three investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, The Cigna Group currently has a consensus rating of “Moderate Buy” and an average price target of $373.69.

The Cigna Group Stock Performance

Shares of CI opened at $292.12 on Tuesday. The business’s 50 day moving average is $286.46 and its two-hundred day moving average is $320.67. The Cigna Group has a 52-week low of $262.03 and a 52-week high of $370.83. The firm has a market cap of $81.25 billion, a price-to-earnings ratio of 23.87, a PEG ratio of 0.94 and a beta of 0.54. The company has a quick ratio of 0.72, a current ratio of 0.66 and a debt-to-equity ratio of 0.70.

The Cigna Group (NYSE:CI) last announced its earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same period last year, the business earned $6.79 earnings per share. Analysts forecast that The Cigna Group will post 29.8 EPS for the current fiscal year.

The Cigna Group Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, March 20th. Stockholders of record on Wednesday, March 5th will be issued a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.07%. This is an increase from The Cigna Group’s previous quarterly dividend of $1.40. The ex-dividend date is Wednesday, March 5th. The Cigna Group’s payout ratio is 45.75%.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.